Ingenion Medical has been awarded a CE Mark for cymactive™ 2.0R, its novel indwelling catheter designed to mimic natural urination, a key milestone for the business. With the CE Mark, Ingenion can start European-wide sales and marketing of the company’s innovative first catheter, indicated for men experiencing chronic, non-neurogenic urinary retention.

Ingenion is seeking to raise up to £3 million this year to support commercialisation of its 1st medical device to treat chronic, non-neurogenic retention, as well as the further development of its device to treat chronic female incontinence & retention.

To date, Ingenion has raised over £4.8 million in equity from High Net Worth Investors and family offices in the UK, the USA and other countries. In addition, Ingenion has been awarded four grants, including its latest grant announced on 10 April 2024.

To find out more about this exciting company and how you can invest go to our Funding Pages website to see the full investment ad.

Read the full press release here https://ingenionmedical.co.uk/ingenion-medical-announces-ce-mark-for-cymactive/

Bridgend-based AI technology firm Clinithink is helping to improve patient care, relieve workloads for stretched clinicians and deliver significant savings to the NHS with investment from the Development Bank of Wales.

New data shows the alarming impact that financial pressures are having on university and business collaboration. Our innovative economy relies on this collaboration to drive growth and prosperity.

Empirical Ventures is targeting a £10M fund to lead pre-seed and seed investments for deep science startups in the UK. Founded by two scientists turned entrepreneurs, Empirical Ventures will invest in startups that are redefining what is possible and solving some of the most pressing challenges facing humanity.

DUBAI: Gingo Partners, an Investor Outreach Service and Startup Community, has completed its fundraising campaign, securing $350k in capital from a group of business angels. 

The Enterprise Investment Scheme (EIS), a cornerstone of the UK's entrepreneurial ecosystem, celebrates its 30th anniversary this year. Since its inception in 1994, the EIS has played a pivotal role in nurturing innovation and fostering economic growth. Alongside its sister scheme, the Seed Enterprise Investment Scheme (SEIS), it has facilitated over £30 billion in private investment into 53,000 startups across the nation.

AB Akola Group has signed an agreement with Brite Drinks Ltd, a UK functional drinks start-up, to invest 450 thousand euros. Akola Group will receive a minority stake in the startup and a seat on its board.

South London-based start-up, B-Corp rated MOMO Kombucha has announced a £1million fund raise.  The brand is also rolling out to Gail’s Bakery nationwide, as well as to Riverford Organic and they have also taken Ocado’s top spot as best-selling soft drink and will achieve 150% revenue growth at the start of ’24, they should hit £3m in revenue this year, marking the boom in kombucha consumption.

The EdTech company, founded by Salisbury mum-of-three Kirstin Coughtrie, has gone through its biggest growth quarter to date – with both significant new angel investments, alongside its learners tripling since the start of this academic school year.

British Business Investments has announced that it is providing a £15m facility to Performance Finance Limited. The transaction will be structured as a block discounting agreement that will allow Performance Finance to provide funding support to smaller businesses looking to acquire business-critical assets to accelerate their growth.

Veremark, a global background screening company, has secured $3 million in a Pre-Series B round led by Samaipata and Stage 2 Capital and including participation from ACF Investors and Vulpes Investment. The investment will be used to support Veremark’s continued client acquisition and further develop its screening technology.

The need for more compliant hiring has become a global requirement, with background screening alone equating to a  $8bn global market in desperate need of innovation.  Veremark provides a global background screening service that helps companies run checks on prospective employees, business partners, limited partners and founders — therefore reducing the risk of hiring or working with underqualified or legally unsuitable people. 

Ingenion Medical has been awarded a £182,890 grant to support its £406,000 development project, to complete development of its next novel device to address chronic urinary control issues.